1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine

BACKGROUND: Hepatitis B (HBV) remains a significant public health risk with an estimated 240-350 million people chronically-infected with HBV worldwide. In the US, rates of new HBV infections are highest among individuals aged 30-39 years, highlighting the elevated risk in adults. Moreover, CDC repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesikari, Timo, Langley, Joanne M, Machluf, Nathalie, Spaans, Johanna, Yassin-Rajkumar, Bebi, Anderson, Dave, Popovic, Vlad, Diaz-Mitoma, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777111/
http://dx.doi.org/10.1093/ofid/ofaa439.1237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777111/
http://dx.doi.org/10.1093/ofid/ofaa439.1237

Ejemplares similares